Abstract
Gangliogliomas (GGs) are rare tumors of the central nervous system occurring in the young population (8.5-25 years). GGs are one of the most common cause of epilepsy associated with CNS tumors and significant proportion of them is refractory to antiepileptic medications. Multifocal gangliogliomas are very rare and only few handful cases are reported. A rare case of multiple spinal ganglioglioma has also been reported in the literature. We present a case of an adolescent girl who presented with multiple episodes of seizures. She was initially evaluated and diagnosed with multiple tuberculomas. She was managed with antiepileptics and antitubercular medications. Her seizure frequency had decreased; but despite prolonged and complete course of anti-tubercular treatment, the lesions were not subsiding in size. Antitubercular medications were restarted and subsequent scan showed progression in the size of the lesions; and hence biopsy was done from the largest lesion. Histopathology was suggestive of GG. Ganglioglioma can be multifocal and can mimic other lesions like tuberculosis, radiologically. Surgical excision of the lesion provides the best treatment option. It is still under consideration whether to remove all of the lesions or only ones with considerable size. She had another episode of seizure and is now planned for surgical excision of the other lesion.
Highlights
Gangliogliomas are primary intra-axial solitary tumors of the central nervous system (CNS), with male preponderance occurring within first three decades of life
GGs usually present with seizures in 90% of cases, and a significant proportion of them are pharmacoresistant [3,4,5]. 40-84% of lesions are located in the temporal lobe, but they can occur in almost any region of CNS [3]
With this, present one of the handfuls of multifocal ganglioglioma cases to add to the limited database for enhancing future study or treatment guidelines
Summary
Akshay Vijay Kulkarni1, *, Gyani Jail Singh Birua1, *, Dhaval Gohil, Manish Beniwal, Dwarakanath Srinivas, Shilpa Rao.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.